Dental and medical products company Henry Schein (NASDAQ:HSIC) missed Wall Street’s revenue expectations in Q1 CY2025, with sales flat year on year at
Graco currently trades at $82.40 per share and has shown little upside over the past six months, posting a small loss of 2.6%.
What a brutal six months it’s been for West Pharmaceutical Services. The stock has dropped 34.8% and now trades at $211, rattling many shareholders. This
Although the S&P 500 is down 2.4% over the past six months, Dillard’s stock price has fallen further to $359, losing shareholders 7.7% of their capital.
(Bloomberg) -- There are many reasons to doubt the rebound in US stocks, but it has at least one powerful factor on its side: momentum. Most Read from
A new measure of CEO compensation that accounts for stock growth is creating some eye-popping numbers.
Volatility cuts both ways - while it creates opportunities, it also increases risk, making sharp declines just as likely as big gains. This
Rock-bottom prices don't always mean rock-bottom businesses. The stocks we're examining today have all touched their 52-week lows, creating a classic
While profitability is essential, it doesn’t guarantee long-term success. Some companies that rest on their margins will lose ground as competition
While profitability is essential, it doesn’t guarantee long-term success. Some companies that rest on their margins will lose ground as competition
